-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OgZZYmbNIko6RX+Qn77JJL3UGGb1grOhbU0Pbj9jQ2dONqe1mkrPCySysJ15PmHw ZNrOyOI7a56xt/UfKS2J2g== 0000950130-98-006080.txt : 19981230 0000950130-98-006080.hdr.sgml : 19981230 ACCESSION NUMBER: 0000950130-98-006080 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19980930 ITEM INFORMATION: FILED AS OF DATE: 19981229 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACEUTICAL RESOURCES INC CENTRAL INDEX KEY: 0000878088 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223122182 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 001-10827 FILM NUMBER: 98777323 BUSINESS ADDRESS: STREET 1: ONE RAM RIDGE RD CITY: SPRING VALLEY STATE: NY ZIP: 10977 BUSINESS PHONE: 9144257100 MAIL ADDRESS: STREET 1: ONE RAM RIDGE RD CITY: SPRING VALLEY STATE: NY ZIP: 10977 8-K 1 FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 205497 ______________________ FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 14, 1998 PHARMACEUTICAL RESOURCES, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER) NEW JERSEY FILE NUMBER 1-10827 22-3122182 (STATE OR OTHER JURISDICTION OF (COMMISSION FILE NUMBER) (I.R.S. EMPLOYER INCORPORATION OR ORGANIZATION) IDENTIFICATION NO.) ONE RAM RIDGE ROAD, SPRING VALLEY, NEW YORK 10977 (ADDRESS OF PRINCIPAL EXECUTIVE OFFICE) (ZIP CODE) Registrant's telephone number, including area code: (914) 425-7100 TOTAL NUMBER OF PAGES -- 2 ITEM 8. CHANGE IN FISCAL YEAR. - ------- --------------------- On December 14, 1998, the Board of Directors of Pharmaceutical Resources, Inc. (the "Registrant") resolved to change the fiscal year of the Registrant from September 30 to December 31. Accordingly, the current fiscal year of the Registrant will commence on January 1, 1999 and will end on December 31, 1999, and the fiscal quarters will end on April 3, 1999, July 3, 1999, October 2, 1999 and December 31, 1999. The periodic report of the Registrant for the transition period (October 1, 1998 through December 31, 1998) will be filed on Form 10-Q. SIGNATURES Pursuant to the requirements of the Securities Exchange of Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. December 29, 1998 PHARMACEUTICAL RESOURCES, INC. ------------------------------ (Registrant) /s/Kenneth I. Sawyer -------------------- Kenneth I. Sawyer President and Chief Operating Officer 2 -----END PRIVACY-ENHANCED MESSAGE-----